2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$0.92+$0.03 (+3.38%)
Price as of Aug 21, 2026 7:57 PM EDT- $23.7MMarket Cap
- -72.28%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$0.92+$0.03 (+3.38%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.89 | ||
Change | $0.00 (0.00%) | ||
Open | $0.92 | ||
High | $0.94 | ||
Low | $0.87 | ||
Previous Close | $0.89 | ||
Volume | 56,786 | ||
30-Day Average Volume | 100,276 | ||
1-Week Change | -1.11% | ||
1-Month Change | -27.65% | ||
1-Year Change | -72.28% | ||
3-Year Change | -55.50% | ||
5-Year Change | -95.62% | ||
Fundamentals | |||
Shares Outstanding | 26.7M | ||
Total Assets | $19.4M | ||
Market Cap | $23.7M | ||
Enterprise Value | $24.1M | ||
Period: QTR TTM FY | |||
Revenue | -$36.00 | ||
Net Income | -$736,934.00 | ||
Free Cash Flow | -$244,413.00 | ||
EBIT | -$736,934.00 | ||
EBITDA | -$730,418.00 | ||
Net Working Capital | -$5.3M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | -668,827 | ||
P/B | 2 | ||
P/E | -30 | ||
PEG | -1 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue